These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 30257989

  • 1. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
    Wang W, Li S, Liu P, Sideras K, van de Werken HJG, van der Heide M, Cao W, Lavrijsen M, Peppelenbosch MP, Bruno M, Pan Q, Smits R.
    Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
    [Abstract] [Full Text] [Related]

  • 2. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S, Dahmani R, Coulouarn C, Ragazzon B, Mlecnik B, Senni N, Savall M, Bossard P, Sohier P, Drouet V, Tournier E, Dumont F, Sanson R, Calderaro J, Zucman-Rossi J, Vasseur-Cognet M, Just PA, Terris B, Perret C, Gilgenkrantz H.
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [Abstract] [Full Text] [Related]

  • 3. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
    Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell P, Tsai HW, Barretina J, Thung S, Ward SC, Bruix J, Mazzaferro V, Schwartz M, Friedman SL, Llovet JM.
    Clin Cancer Res; 2012 Sep 15; 18(18):4997-5007. PubMed ID: 22811581
    [Abstract] [Full Text] [Related]

  • 4. Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling.
    Wang W, Xu L, Liu P, Jairam K, Yin Y, Chen K, Sprengers D, Peppelenbosch MP, Pan Q, Smits R.
    Neoplasia; 2016 Dec 15; 18(12):711-723. PubMed ID: 27851986
    [Abstract] [Full Text] [Related]

  • 5. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 6. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL, Yang ZW, Wang J, Zhang XL, Chen XM, Lu FM.
    World J Gastroenterol; 2015 May 28; 21(20):6317-28. PubMed ID: 26034368
    [Abstract] [Full Text] [Related]

  • 7. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y.
    Nat Genet; 2000 Mar 28; 24(3):245-50. PubMed ID: 10700176
    [Abstract] [Full Text] [Related]

  • 8. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W.
    Oncogene; 2002 Jul 18; 21(31):4863-71. PubMed ID: 12101426
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH, Feng WC, Lu LC, Shao YY, Hsu CH, Cheng AL.
    Cancer Lett; 2016 Oct 10; 381(1):58-66. PubMed ID: 27431312
    [Abstract] [Full Text] [Related]

  • 10. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, Jin H, Choy KW, Yu J, To KF, Wong N, Huang TH, Sung JJ.
    Cancer Res; 2011 Jun 01; 71(11):4028-39. PubMed ID: 21512140
    [Abstract] [Full Text] [Related]

  • 11. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 12. β-Catenin signaling in hepatocellular carcinoma.
    Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X.
    J Clin Invest; 2022 Feb 15; 132(4):. PubMed ID: 35166233
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol 4-phosphate adaptor protein 2 accelerates the proliferation and invasion of hepatocellular carcinoma cells by enhancing Wnt/β-catenin signaling.
    Fan W, Du F, Liu X.
    J Bioenerg Biomembr; 2020 Oct 15; 52(5):301-309. PubMed ID: 32914361
    [Abstract] [Full Text] [Related]

  • 14. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K, Li C, Zhang X, Shang L.
    Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 30996112
    [Abstract] [Full Text] [Related]

  • 15. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, Li HJ, Lin YW.
    Hepatology; 2012 Dec 31; 56(6):2277-87. PubMed ID: 22767186
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC, Zhang T, Li Y, Wang GY.
    Oncotarget; 2015 Apr 10; 6(10):7866-79. PubMed ID: 25797263
    [Abstract] [Full Text] [Related]

  • 17. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
    Shih YL, Hsieh CB, Lai HC, Yan MD, Hsieh TY, Chao YC, Lin YW.
    Int J Cancer; 2007 Sep 01; 121(5):1028-35. PubMed ID: 17443492
    [Abstract] [Full Text] [Related]

  • 18. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY, He YH, Chen C, Xu T, Li L, Ni MM, Meng XM, Huang C, Li J.
    Cancer Lett; 2016 Jun 28; 376(1):10-21. PubMed ID: 26975630
    [Abstract] [Full Text] [Related]

  • 19. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C, Ho YJ, Salomao MA, Dapito DH, Bartolome A, Schwabe RF, Lee JS, Lowe SW, Pajvani UB.
    J Hepatol; 2021 Mar 28; 74(3):613-626. PubMed ID: 33038431
    [Abstract] [Full Text] [Related]

  • 20. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H, Li Y, Li X, Zhang W, Li S, Martin RCG.
    BMC Cancer; 2018 Aug 03; 18(1):783. PubMed ID: 30075764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.